Treatment
FDA Approves Ketamine for Treatment-Resistant Depression
Last Updated on August 10, 2023 Yesterday, on March 5, 2019, the FDA approved the use of ketamine for treatment-resistant depression. The new drug Spravato
March 6, 2019
No Comments